Added to YB: 2026-10-09
Pitch date: 2026-10-04
NAGE [bullish]
Niagen Bioscience, Inc.
-7.53%
current return
Author Info
No bio for this author
Company Info
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Market Cap
$213.3M
Pitch Price
$2.79
Price Target
N/A
Dividend
N/A
EV/EBITDA
13.56
P/E
14.15
EV/Sales
1.15
Sector
Personal Care Products
Category
growth
M&A Hunter Portfolio Update: Tier 3 Core Convictions (Under $10) - Niagen Bioscience, Inc.
NAGE (hold): Niagen Bioscience, at $2.76, is a consumer-health growth thesis centered on the Niagen NAD franchise rather than a traditional biotech acquisition setup. Brand momentum, direct-to-consumer economics, distribution expansion and sustained demand matter more than clinical or regulatory events. A wellness, nutrition or longevity buyer could eventually emerge, but the differentiated strategic logic keeps the position in the satellite sleeve.
Read full article (1 min)